Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In this study, 147 smokers were randomly assigned to receive either venlafaxine or placebo in conjunction with behavioral counseling (9 weekly sessions) and transdermal nicotine replacement therapy (22 mg/day). Patients began medication 2 weeks before quitting and continued for 18 weeks after quitting, with the daily dose titrated from 150 to 225 mg. in response to symptoms of negative affect and relapse. The results showed no main effect of treatment on abstinence. Post hoc analysis revealed that both at the end of treatment and at the 1-year follow-up smokers consuming less than a pack of cigarettes a day benefited from the addition of venlafaxine to the treatment regimen. Venlafaxine also reduced negative affect for all smokers for up to 6 weeks postcessation. The findings suggest that venlafaxine could have some role to play in the treatment of lighter smokers, in addition to the expected benefits of nicotine replacement therapy and behavioral counseling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
First lapses to smoking: Within-subjects analysis of real-time reports.
Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.366 · Cited by 745
Tobacco withdrawal in self-quitters
Hughes, J. R. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.60.5.689 · Cited by 412
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Fiore, M. C., & Staff, G. P. A. (2000) · Respiratory Care · doi:10.1177/002013240004501007 · Cited by 346
Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P. L., Wolter, T. D., Buist, A. S., Johnston, J. A., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00011 · Cited by 343
Smoking cessation among self-quitters.
Hughes, J. R., Gulliver, S. B., Fenwick, J. W., Valliere, W. A., Cruser, K., Pepper, S., Shea, P., Solomon, L. J., & Flynn, B. S. (1992) · Health Psychology · doi:10.1037/0278-6133.11.5.331 · Cited by 269
Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. L., & Hurt, R. D. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.2.173 · Cited by 264
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189
Cited by
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 348
Interventions for preventing weight gain after smoking cessation
Farley, A. C., Hajek, P., Lycett, D., & Aveyard, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub3 · Cited by 334
Past major depression and smoking cessation outcome: A systematic review and meta-analysis update
Hitsman, B., Papandonatos, G. D., McChargue, D. E., DeMott, A., Herrera, M. J., Spring, B., Borrelli, B., & Niaura, R. (2013) · Addiction · doi:10.1111/add.12009 · Cited by 162
Metadata
- Authors
- Cinciripini, P. M., Tsoh, J. Y., Wetter, D. W., Lam, C., de Moor, C., Cinciripini, L., Baile, W., Anderson, C., & Minna, J. D.
- Venue
- Experimental and Clinical Psychopharmacology
- Published
- 2005
- Volume
- 13
- Issue
- 4
- Pages
- 282-292
- ISSN
- 1064-1297 (ISSN-L)
- 1936-2293
- OpenAlex
- W2036168588
- Cited by
- 44
- References
- 12
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. https://app.cochat.ai/papers/10.1037/1064-1297.13.4.282
- The paper
- Cinciripini, P. M., Tsoh, J. Y., Wetter, D. W., Lam, C., de Moor, C., Cinciripini, L., Baile, W., Anderson, C., & Minna, J. D. (2005). Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/1064-1297.13.4.282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.